Search

everythinglearnresearchcommunity

for

Search:↓

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Semaglutide may help some skin disorders but can also cause skin issues.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

A new method helps isolate key hair components to study hair growth and loss.

Phototherapy is often used for psoriasis in children, but it has low success rates.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Targeting colon cancer stem cells might lead to better treatment results.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.